Zantac

Delaware Supreme Court to Review Key Legal Challenges in Massive Zantac Cancer Case

by

Dover, Delaware — Home to more than two-thirds of Fortune 500 companies, Delaware is a beacon of corporate incorporation. The state’s reputation as a legal hub for business is now under the spotlight as the Delaware Supreme Court considers a pivotal appeal that could redefine its approach to mass-tort litigation. Delaware recently came to the forefront of legal discussions due to a substantial case involving over 75,000 plaintiffs. These individuals allege that ranitidine, often sold under the brand name Zantac, is carcinogenic. They argue that the drug breaks down into N-nitrosodimethylamine (NDMA), a substance believed … Read more

Zantac Ruling in Delaware Could Transform State into Mass Torts Hub

by

Wilmington, DE — A recent ruling by a Delaware judge denying the consolidation of approximately 140 lawsuits against the manufacturers of Zantac could position the state as a new focal point for mass tort litigation. The decision by the Superior Court in Wilmington diverges notably from trends in other states where large-scale pharmaceutical lawsuits have been consolidated. The plaintiffs in these cases allege that Zantac, a popular over-the-counter heartburn medication, caused a variety of cancers. The claims have been spurred by studies indicating that the drug could turn into a carcinogenic substance under certain conditions. … Read more

Another Chicago Jury Declines to Award Damages in Zantac Cancer Lawsuit, as California Trial Begins

by

Chicago, IL — A Cook County Circuit Court jury recently declared a mistrial in a lawsuit concerning the heartburn medication Zantac, marking the fourth such outcome in Chicago courts. These proceedings revolve around allegations that the manufacturer, Boehringer Ingelheim, failed to warn users that the drug could allegedly lead to cancer. This recent decision follows close on the heels of two other similar outcomes involving Zantac disagreements, with the notable instance last month when another jury reached a decision against GlaxoSmithKline, a different manufacturer of the same medication. The legal battles are far from confined … Read more

Could Delaware Become the Go-To State for Product Liability Lawsuits? Insights from the Zantac Case

by

Wilmington, Delaware — A recent wave of litigation centered around the heartburn medication Zantac is spotlighting Delaware as a potentially preferred venue for plaintiffs in pharmaceutical cases. The shift follows legal allegations that the drug, which was pulled from the market in 2020, may have caused cancer in numerous users. Legal experts suggest this trend toward filing in Delaware could be influenced by several key factors that make the state an attractive option for lawsuits. Delaware is renowned for its sophisticated understanding of corporate law, largely due to its role as a corporate domicile for … Read more